Results 131 to 140 of about 5,892 (166)

Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry. [PDF]

Can J Kidney Health Dis
McFarlane P, Bichet DG, Alam A, Bubolic S, Laplante A.   +4 more
europepmc   +1 more source

Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Real-World Insights from a Propensity Score Weighted Retrospective Cohort Study.

Am J Nephrol
Marshall WR, Chinnadurai R, Rengarajan S, De Bhailís Á, Gorton J, Kalra PA, Wood G.   +6 more
europepmc   +1 more source

Long-Term Tolvaptan Administration in Chinese Patients with Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study in Real Clinical Practice.

Kidney Blood Press Res
Li M, Sun M, Cui S, Liu X, Guo M, Xiao Y, Huang Y, Zhou S, Wang H, Chen X, Li Q.   +10 more
europepmc   +1 more source

Efficacy of Low-Dose Tolvaptan for Treatment of Profound Hyponatremia in Syndrome of Inappropriate Antidiuresis (SIAD): The EFFLUX-FLUID TRIAL. [PDF]

Kidney Med
Jaiyen N, Chinpraditsuk S, Pattharanitima P, Tantiyavarong P, Krisanapan P.   +4 more
europepmc   +1 more source

Randomized Controlled Trial Evaluating Rotigotine Safety in PKD. [PDF]

Kidney Int Rep
Dumont A, Cour A, Quillard-Murraine M, Van Wynsberghe M, Ruault S, Prod'Homme S, Houivet E, Choukroun G, Renard C, Béchade C, Claudinot A, Glowacki F, Puech P, Marty N, Buchbach V, Donnadieu N, Duhamel E, Dacher JN, Guerrot D, Bellien J.   +19 more
europepmc   +1 more source

Tolvaptan pharmacokinetics and pharmacodynamics in adolescents with autosomal dominant polycystic kidney disease. [PDF]

Eur J Pediatr
Shoaf SE, Sikes K.
europepmc   +1 more source

Comparative Strategies to Overcome Diuretic Resistance in Heart Failure: A Network Meta-Analysis. [PDF]

JACC Adv
Lima IG, Nunes JT, Luk AC, Brahmbhatt DH, Godoy LC, McDonald M, Billia F, Bocchi EA.   +7 more
europepmc   +1 more source

Validation of Combining Total Kidney Volume and Kidney Failure Risk Equation in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Kidney Int Rep
Bevilacqua M, Guan M, Romann A, Er L, Shao T, Farah M, Elliott MD.   +6 more
europepmc   +1 more source

Clinical significance of urinary sodium measurement for predicting pulmonary decongestion: a prospective observational study. [PDF]

Heart Vessels
Oguri M, Okumura T, Kojima S, Maeda S, Yoshida S, Koyama Y, Ishiguro T, Fujikawa Y, Takahashi H, Murohara T, Ishii H.   +10 more
europepmc   +1 more source

Prognostic Performance of Ellipsoid Kidney Volume Measurement in a Computed Tomography-Heavy ADPKD Cohort: A Retrospective Observational Cohort Study. [PDF]

Can J Kidney Health Dis
Abdrabou M, Akbari A, Shabana W, Biyani M, Hundemer GL, Sood MM, Chapman AB, Fremont D, Brown PA.   +8 more
europepmc   +1 more source